Patent directory · USPTO A61K / A61P
Patents matching “REGENERON PHARMACEUTICALS, INC.”
837 pharma patents match "REGENERON PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 837 pharmaceutical patents matching "REGENERON PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12344677
Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof
granted -
US 12344654
Mage A4 T cell receptors
granted -
US 12344665
Treatment of fibrodysplasia ossificans progressiva by administration of an anti-activin a antibody
granted -
US 12338199
Bis-octahydrophenanthrene carboxamides and protein conjugates thereof
granted -
US 12338274
Anti-VEGF protein compositions and methods for producing the same
granted -
US 12337199
Stable antibody formulation
granted -
US 12331127
Therapeutic uses of anti-GITR antibodies
granted -
US 12331109
Antigen binding molecule formats
granted -
US 12331099
VEGF antagonist formulations suitable for intravitreal administration
granted -
US 12325752
Immunoglobulin proteins that bind to NPR1 agonists
granted -
US 12319724
IL2 agonists and methods of use thereof
granted -
US 12319728
Anti-VEGF protein compositions and methods for producing the same
granted -
US 12317874
Method of using a genetically modified mouse that expresses human albumin
granted -
US 12304969
Factor XI A2 domain-binding antibodies and methods of use thereof
granted -
US 12297207
Maytansinoid derivatives, conjugates thereof, and methods of use
granted -
US 12297279
Compositions and methods for treating pain in subjects with rheumatoid arthritis
granted -
US 12297465
CBLB endonuclease variants, compositions, and methods of use
granted -
US 12297257
Multispecific antigen-binding molecules and uses thereof
granted -
US 12291559
Compositions and methods for treating cancer
granted -
US 12291560
Dimerizing agent regulated immunoreceptor complexes
granted -
US 12291571
Methods for reducing eosinophilic infiltration by administering an anti-interleukin-4 receptor (IL4R) antibody
granted -
US 12281173
Methods for treating patients with hyperlipidemia by administering a PCSK9 inhibitor in combination with an ANGPTL3 inhibitor
granted -
US 12280124
Antibody-drug conjugates comprising GLP1 peptidomimetics and uses thereof
granted -
US 12280093
Use of a VEGF receptor-based fusion protein antagonist to treat nonproliferative diabetic retinopathy
granted